<abstract xmlns="http://www.w3.org/1999/xhtml"><p> Advances in the understanding of haemophilia require effective collaboration, both at the national and international levels. Such collaborations are currently playing a major role in elucidating the natural history of acquired haemophilia, and also in clarifying the issue of product-related inhibitor development in previously untreated patients with haemophilia.</p></abstract>

Advances in the understanding of haemophilia require effective collaboration, both at the national and international levels. Such collaborations are currently playing a major role in elucidating the natural history of acquired haemophilia, and also in clarifying the issue of product-related inhibitor development in previously untreated patients with haemophilia.

Diagnosis and management of inhibitors: the need for professional collaboration

The Journal of Haemophilia Practice

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

{"article-title":"Diagnosis and management of inhibitors: the need for professional collaboration"}

Advances in the understanding of haemophilia require effective collaboration, both at the national and international levels. Such collaborations are currently...

Diagnosis and management of inhibitors: the need for professional collaboration

Article Category: Kd50: My Story

Data publikacji: 21 kwi 2018

Zakres stron: 8 - 10

DOI: https://doi.org/10.17225/jhp00050

Słowa kluczowe
inhibitor, haemophilia, Katharine Dormandy

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Diagnosis and management of inhibitors: the need for professional collaboration

Article Category: Kd50: My Story

Data publikacji: 21 kwi 2018

Zakres stron: 8 - 10

DOI: https://doi.org/10.17225/jhp00050

Słowa kluczoweinhibitor, haemophilia, Katharine Dormandy

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Słowa kluczowe
inhibitor, haemophilia, Katharine Dormandy